GRADUALLY INCREASING DOSES OF PREDNISONE IN MYASTHENIA-GRAVIS - REDUCING HAZARDS OF TREATMENT

被引:161
作者
SEYBOLD, ME [1 ]
DRACHMAN, DB [1 ]
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA
关键词
D O I
10.1056/NEJM197401102900204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:81 / 84
页数:4
相关论文
共 18 条
[1]   CORTICOSTEROIDS IN MANAGEMENT OF SEVERE, GENERALIZED MYASTHENIA-GRAVIS - EFFECTIVENESS AND COMPARISON WITH CORTICOTROPIN THERAPY [J].
BRUNNER, NG ;
NAMBA, T ;
GROB, D .
NEUROLOGY, 1972, 22 (06) :603-&
[2]  
DALBY A, 1971, LANCET, V1, P597
[3]   USE OF ACTH AND CORTICOSTEROIDS IN MYASTHENIA GRAVIS [J].
GENKINS, G ;
KORNFELD, P ;
OSSERMAN, KE ;
NAMBA, T ;
GROB, D ;
BRUNNER, NG .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 183 (NSEP) :369-&
[4]  
GROB D, 1952, B JOHNS HOPKINS HOSP, V91, P124
[5]   RATIONALE OF ALTERNATE-DAY CORTICOSTEROID THERAPY [J].
JACOBSON, ME .
POSTGRADUATE MEDICINE, 1971, 49 (02) :181-&
[6]  
JENKINS RB, 1972, LANCET, V1, P765
[7]   THE EFFECT OF CERTAIN ENDOCRINE GLANDS ON MYASTHENIA GRAVIS [J].
KANE, CA .
AMERICAN JOURNAL OF MEDICINE, 1955, 19 (05) :729-733
[8]   MYASTHENIA GRAVIS AND MYASTHENIC SYNDROMES TREATED WITH PREDNISONE [J].
KJAER, M .
ACTA NEUROLOGICA SCANDINAVICA, 1971, 47 (04) :464-&
[9]   CLINICAL EVALUATION OF ACTH AND CORTISONE IN MYASTHENIA GRAVIS [J].
MILLIKAN, CH ;
EATON, LM .
NEUROLOGY, 1951, 1 (02) :145-152
[10]   CORTICOTROPIN THERAPY IN MYASTHENIA GRAVIS - EFFECTS, INDICATIONS, AND LIMITATIONS [J].
NAMBA, T ;
BRUNNER, NG ;
SHAPIRO, MS ;
GROB, D .
NEUROLOGY, 1971, 21 (10) :1008-&